Short Interest in CSL Limited (OTCMKTS:CSLLY) Increases By 3,400.0%

CSL Limited (OTCMKTS:CSLLY) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 17,500 shares, an increase of 3,400.0% from the October 15th total of 500 shares. Based on an average trading volume of 52,300 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analyst Weigh In

Separately, Macquarie raised shares of CSL to a “strong-buy” rating in a research note on Tuesday, August 13th.

CSL Stock Performance

OTCMKTS CSLLY opened at $92.90 on Wednesday. CSL has a 12 month low of $79.95 and a 12 month high of $109.00. The company has a 50-day moving average of $98.59 and a 200-day moving average of $98.30. The company has a quick ratio of 0.97, a current ratio of 2.18 and a debt-to-equity ratio of 0.58.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.